Written question asked by Paul Burstow (Liberal Democrat) on Tuesday, 10 March 2015, in the House of Commons. It was due for an answer on Thursday, 12 March 2015. It was answered by George Freeman (Conservative) on Tuesday, 17 March 2015 on behalf of the Department of Health.
Co-careldopa
- Question
-
To ask the Secretary of State for Health, pursuant to the Answer to Question 224953 of 2 March 2015, whether Duodopa was considered for funding by NHS England for routine funding in the 2013-14 financial year.
- Answer
-
NHS England has advised that the draft clinical policy for recommending the funding of Duodopa was presented and considered in 2014-15. Before this time, the commissioning responsibility for Duodopa rested with clinical commissioning groups.
Secondary information
- Type
- Written question
- Reference
- 227025
- Session
- 2014-15
- Related items
- Subjects
- Co-careldopa
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2024-05-29 09:07:58 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/227025
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/227025
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/227025